These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 11798469

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications.
    Wang YS, Youngster S, Grace M, Bausch J, Bordens R, Wyss DF.
    Adv Drug Deliv Rev; 2002 Jun 17; 54(4):547-70. PubMed ID: 12052714
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.
    Youngster S, Wang YS, Grace M, Bausch J, Bordens R, Wyss DF.
    Curr Pharm Des; 2002 Jun 17; 8(24):2139-57. PubMed ID: 12369859
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pegylation and Cell Based Bioassay of Human Interferon-α2b Along its Docking Studies and Effect on Plasma Half-Life.
    Shahzadi SK, Qadir MA, Mahmood N, Ahmed M.
    Protein Pept Lett; 2020 Jun 17; 27(3):219-224. PubMed ID: 31612813
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cells.
    Vyas K, Brassard DL, DeLorenzo MM, Sun Y, Grace MJ, Borden EC, Leaman DW.
    J Immunother; 2003 Jun 17; 26(3):202-11. PubMed ID: 12806274
    [Abstract] [Full Text] [Related]

  • 12. Effect of pegylation on self-association of IFN-α2b.
    Mohs A, Ambrogelly A, Yang X, Haverick M, Cheung JK, Narasimhan C, Shameem M.
    Mol Pharm; 2014 Jan 06; 11(1):158-63. PubMed ID: 24266549
    [Abstract] [Full Text] [Related]

  • 13. Identification of the major positional isomer of pegylated interferon alpha-2b.
    Wang YS, Youngster S, Bausch J, Zhang R, McNemar C, Wyss DF.
    Biochemistry; 2000 Sep 05; 39(35):10634-40. PubMed ID: 10978146
    [Abstract] [Full Text] [Related]

  • 14. Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity.
    Monkarsh SP, Ma Y, Aglione A, Bailon P, Ciolek D, DeBarbieri B, Graves MC, Hollfelder K, Michel H, Palleroni A, Porter JE, Russoman E, Roy S, Pan YC.
    Anal Biochem; 1997 May 01; 247(2):434-40. PubMed ID: 9177709
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pegylating IFNs at his-34 improves the in vitro antiviral activity through the JAK/STAT pathway.
    Grace MJ, Cutler D.
    Antivir Chem Chemother; 2004 Nov 01; 15(6):287-97. PubMed ID: 15646642
    [Abstract] [Full Text] [Related]

  • 17. [Obtaining and characteristics of domestic preparation interferon alpha-2b with prolonged effect].
    Pokholenko IaA, Porubleva LV, Dubeĭ IIa, Rebriev AV, Sutugina LP, Gromovoĭ TIu, Pokrovskiĭ VA, Obolenskaia MIu, Chernykh SI.
    Ukr Biokhim Zh (1999); 2008 Nov 01; 80(6):92-100. PubMed ID: 19351063
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ, Fam CM, Chlipala EA, Carlson SJ, Lee JI, Rosendahl MS, Doherty DH, Cox GN.
    Bioconjug Chem; 2008 Jan 01; 19(1):299-305. PubMed ID: 18020402
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.